ITLN1 and type 2 diabetes mellitus: Clinically, decreased plasma omentin levels have been consistently observed in patients with T2DM, while individual studies have also assessed parameters such as fasting glucose and the Homeostatic model assessment of insulin resistance (HOMA-IR) index [4,37].